Iris Ventures, the investment management firm led by Montse Suárez, has announced the successful first closing of its second fund, IRIS Fund II, securing between €90 and €100 million in record time.
The IRIS Fund II, targeting a total size of €200 million, is dedicated to investing in innovative consumer companies across sectors such as beauty, nutrition, wellness, longevity, and new lifestyles. The investment thesis proposed by Iris Ventures stands out for being intentionally removed from artificial intelligence and deep tech. Moreover, all the capital comes from leading European family offices linked to the consumer sector, with no public funding involved.
With this new vehicle, Iris Ventures plans to increase its average investment ticket, deploying between €5 million and €20 million per company in advanced growth-stage scale-ups, which will receive long-term support over a five-year period, including the participation of two Iris Ventures representatives on their boards. The firm’s objective is to complete 12 to 15 investments over the next four years, with 80% of its capital deployed in Europe and 20% in the United States.
Montse Suárez, founder and sole partner of Iris Ventures, stated: “The success of this first closing in record time for our second fund demonstrates that, for us at Iris Ventures, investing with purpose has both soul and return. With IRIS Fund II, we are partnering with the best family offices to empower the brands that are redefining modern consumerism. We have a unique investment thesis, with a mission to drive the next generation of leading brands that will transform and improve consumers’ lives.”
IRIS Fund II: Continuing a Proven Growth Journey
The Iris Fund II is the firm’s second investment vehicle. The first, launched in 2021, reached a total of €100 million in committed capital. To date, the firm has completed 12 investments, with a portfolio that includes Spanish companies such as Olistic (hair care), Essentialist (luxury travel), Superlativa (health supplements), and the burger chain VICIO, as well as international brands such as Swedish sports nutrition company Maurten, UK wellness platform Healf, and Italian design and craftsmanship brand Artemest.
About Iris Ventures
Iris Ventures is a thematic growth fund investing in high-potential consumer brands and technology-driven solutions across Europe, the UK, and the United States. With a focus on building healthier, happier, and more convenient lives, Iris partners with businesses that have the potential to lead category definition in beauty, health, wellness, lifestyle, nutrition, daily tech, and modern commerce.
The firm brings deep expertise in beauty brand building, combining in-depth industry knowledge, a global network, and a proven track record in supporting innovation. Iris Ventures has backed leading consumer brands including Maurten, Olistic, Healf, Superlativa, VICIO, Artemest, Biomel, Mammaly, Essentialist, and Saysh.
cloud technology axon
Thanks to the support of CDTI Innovación, the Catalan company Abrasto...
